How does overactivation of the complement system affect lesion development and progression of geographic atrophy? Read to learn the latest insights from Dr. Khanani. ow.ly/reje50VWu7q

[ NEW ] KOL KNOCKOUT™: Medical Retina Edition Competing for the Best Outcomes in Retina: ow.ly/ft6050VYiYP

On the latest New #Retina Radio Journal Club with VBS, Drs. Lediana Goduni, Alexis Warren, and Joshua Uhr unpack a TriNetX-based study on GLP-1s and age-related ocular disease risk—and debate whether these data should change how we counsel patients: ow.ly/hQQT50VXSTJ

At ARVO 2025, New Retina Radio sat down with Drs. David Miller and Robert Wang to review real-world dosing of next-gen anti-VEGFs and the state of TKIs. Listen here 🎧: ow.ly/jAcP50W0RN7

Drs. Fehrina Ali and Roger Goldberg review how sustained-release tyrosine kinase inhibitors may enable retinal specialists to extend treatment intervals for nAMD patients and reduce injection burden. Read more: bit.ly/43Ci8pk #sponsored #DURAVYU #vorolanib #EYP1901

Gain a firmer grasp on OCTA's potential to improve your diagnosis and characterization of disease in this dialogue between Yasha Modi, MD, and Katherine Talcott, MD: ow.ly/IrSz50W1Io5 #sponsored

Want to catch up on ARVO talks? We’ve got you covered with video highlights on Eyetube! ARVO faculty discuss diabetes care, including novel therapies under investigation and the effect of new systemic meds on the eye: ow.ly/tq1Z50W2NGU

Rene Choi, MD, PhD, is our next One to Watch! He knew retina was his place after conducting research on retinal regeneration in a frog model of retinitis pigmentosa. Learn more about Dr. Choi’s background, mentors, and pearls for new surgeons here: ow.ly/3rKt50W3ze7

📣 Register now to attend 💻🗣️ Photobiomodulation Coding, Billing, and Reimbursement—a webinar on reimbursement considerations for the Valeda® Light Delivery System for dry AMD. Save your seat for 6/26 at 8:30pm EDT! ow.ly/byoS50W4TSh #sponsored

Adrian Au, MD, PhD, is our next ⭐️Rising Star in Retina ⭐️ He is a 2nd-year vitreoretinal surgery fellow at UCLA, and he hopes to contribute to diagnostic and therapeutic innovations during his career. Learn more about his path to retina here: ow.ly/ctRq50W5CcB

Did you miss ARVO this year? We didn’t, and we have your video meeting highlights to catch you up on the latest happenings. Experts share pearls on treating GA, treatment-naïve wet AMD, and symptomatic vitreous floaters: ow.ly/MSoZ50W6rQu

Explore innovations in retinal care in the May/June issue of Retina Today! From gene therapy to AI chatbots, see how we're reshaping AMD management. Read more at RetinaToday.com.

[💻🗣️ Webinar] Navigating Valeda reimbursement pathways for dry AMD treatment. Register now for the webinar on Thursday, June 26! ow.ly/bWm150W7WH3 #sponsored

At ARVO 2025, New Retina Radio sat down with Drs. Marion Munk and Diana Do to discuss antisense oligonucleotide targeting of TGF-beta in wet AMD/DME and the latest data on photobiomodulation. Listen here 🎧: ow.ly/pppu50W8jcW

We had a fantastic time at the 2025 Duke AVS Course, and we captured many of the highlights on video! Check out our meeting coverage, now available on Eyetube. ow.ly/JSXO50W95GT

Exclusively available from Bausch + Lomb, the Cohen-Benner Surgical Contact Lens brings clarity and stability to your surgical experience with excellent visualization of the macula. Lens on. Hands off. Learn more at ow.ly/WRnT50Wanrs #bauschsurgical #ophthalmology #ad

Calling all incoming 1st-year retina fellows! Register NOW for the 15th Annual Mass Eye and Ear Vitrectomy Course! Join us July 11-12 in Boston for this unique workshop that covers the theory and practice of vitreoretinal surgery: ow.ly/G9bF50Wb8nc #ad

The 2025 Duke AVS Course was packed with top-notch education, and we have video highlights for you! Experts shared pearls for multimodal imaging, AI in clinical trials, GLP-1 receptor agonists and DR, MTM, and more. Check it out: ow.ly/OK2950WbWLe

⚠️ Last chance to register! ⚠️ Join “Photobiomodulation Coding, Billing, and Reimbursement” to gain practical guidance on navigating reimbursement pathways for Valeda treatment for dry AMD. Register now for the webinar on 6/26: ow.ly/e0qt50Wc4np #sponsored

Predatory "cell therapy" clinics are on the decline. How many still remain? Join Drs. Maria Berrocal and Ajay Kuriyan on Clinical Minute: Retina to find out ➡️ ow.ly/NUT650Wc4pc